论文部分内容阅读
目的:观察和研究采用多潘立酮治疗慢性胃炎的临床疗效。方法:选取2014年5月~2015年5月期间于我院接受治疗的慢性胃炎患者100例,将其随机分为对照组与观察组,每组各50例,前者口服法莫替丁治疗,后者口服多潘立酮治疗,比较两组的临床疗效。结果:治疗前两组患者的症状积分无显著差异,P>0.05,治疗1周、2周后,两组的积分均有所降低,但观察组远小于对照组,P<0.05,差异显著;观察组患者治疗的总有效率为96.0%,大于对照组(78.0%),P<0.05,差异显著。结论:采用多潘立酮治疗慢性胃炎,能够有效减轻和缓解患者的临床症状,具有促进胃排空、协调胃运动的作用,能够改善患者的临床质量,疗效理想,值得推广。
Objective: To observe and study the clinical efficacy of domperidone in the treatment of chronic gastritis. Methods: One hundred patients with chronic gastritis who were treated in our hospital from May 2014 to May 2015 were selected and randomly divided into control group and observation group, with 50 patients in each group. The former was treated with famotidine, The latter oral domperidone treatment, the clinical efficacy of the two groups were compared. Results: There was no significant difference in symptom scores between the two groups before treatment (P> 0.05). After 1 week and 2 weeks of treatment, the scores of both groups decreased, but the observation group was much smaller than the control group (P <0.05) The total effective rate of observation group was 96.0%, which was significantly higher than that of control group (78.0%), P <0.05. Conclusion: The treatment of chronic gastritis with domperidone can effectively alleviate and alleviate the clinical symptoms of patients, promote gastric emptying and coordinate gastric motility, and improve the clinical quality of patients. The therapeutic effect is ideal and worthy of promotion.